14-day Premium Trial Subscription Try For FreeTry Free

Exact Sciences (EXAS) Q1 Earnings Top Estimates, Sales View Up

02:25pm, Wednesday, 27'th Apr 2022 Zacks Investment Research
Robust performances by the Screening and Precision Oncology segments drove Exact Sciences' (EXAS) first-quarter top line.

Charles River (CRL) to Report Q1 Earnings: What's in Store?

02:24pm, Wednesday, 27'th Apr 2022 Zacks Investment Research
Robust global demand for the research model and multiple initiatives to expedite the discovery process are likely to have contributed to Charles River's (CRL) first-quarter results.

Henry Schein (HSIC) to Report Q1 Earnings: What's in Store?

01:01pm, Wednesday, 27'th Apr 2022 Zacks Investment Research
Robust demand in the global dental market with the steady improvement in patient traffic is likely to have contributed to Henry Schein's (HSIC) Q1 performance.

Fulgent Genetics (FLGT) to Post Q1 Earnings: What's in Store?

12:38pm, Monday, 25'th Apr 2022 Zacks Investment Research
Strategic investments and expanding operations in China are likely to have contributed to Fulgent Genetics' (FLGT) first-quarter performance.

3 Medical Product Stocks Poised to Beat This Earnings Season

11:54am, Monday, 25'th Apr 2022 Zacks Investment Research
Medical product companies' results are likely to reflect base business recovery on a year-over-year basis. Let's see how ALC, ZBH and CSII are poised ahead of their earnings releases.
Medical product companies' results are likely to reflect base business recovery on a year-over-year basis. Let's see how ALC, ZBH and CSII are poised ahead of their earnings releases.

LabCorp (LH) to Report Q1 Earnings: What's in the Cards?

03:22pm, Friday, 22'nd Apr 2022 Zacks Investment Research
Robust base business growth and notable launches are likely to have contributed to LabCorp's (LH) Q1 performance.

Align Technology (ALGN) to Post Q1 Earnings: What's in Store?

01:05pm, Thursday, 21'st Apr 2022 Zacks Investment Research
Robust demand for iTero scanners and increasing Invisalign case submissions are expected to have contributed to Align Technology's (ALGN) Q1 performance.

Zacks Industry Outlook Highlights Alcon, STERIS and Abiomed

10:21am, Wednesday, 20'th Apr 2022 Zacks Investment Research
Alcon, STERIS and Abiomed have been highlighted in this Industry Outlook article.

3 Medical Instruments Stocks to Buy Despite Industry Headwinds

12:51pm, Tuesday, 19'th Apr 2022 Zacks Investment Research
The Zacks Medical - Instruments industry is growing on R&D investments. ALC, STE and ABMD are set to gain the most. Yet, demand for non-COVID businesses is on the decline with the new COVID variant di
The Zacks Medical - Instruments industry is growing on R&D investments. ALC, STE and ABMD are set to gain the most.

4 'Double Discounted' CEFs Yielding Up To 9.1%

09:08am, Thursday, 14'th Apr 2022 Investing.com

Alcon (ALC) Stock Rallies 4.7% Since Posting Q4 Earnings Beat

02:36pm, Tuesday, 12'th Apr 2022 Zacks Investment Research
Alcon (ALC) stock rallies on robust growth across all Surgical and Vision Care sales categories.
Alcon (ALC) stock rallies on robust growth across all Surgical and Vision Care sales categories.

Alcon's (ALC) Surgical Arm Rebounds, New Launches Aid Growth

02:37pm, Monday, 11'th Apr 2022 Zacks Investment Research
In Vision Care, Alcon (ALC) continues to see strong demand for PRECISION1 and PRECISION1 for Astigmatism, which are the company's newest contact lenses for the mainstream market.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE